Abbio XR, Inc. Overview
- Industry
- Biotechnology Research
- Employees
- 3
- Founded
- 2024
- Funding
- 5
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Abbio XR, Inc.
Abbio XR is dedicated to transforming peptide therapeutics with our extended release platform technology. Our mission is to reduce adverse effects and remove the need for frequent GLP-1 dosing, making it possible to administer treatments every three months rather than weekly.
Abbio XR, Inc. Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
Abbio XR, Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Andrew Coath | Science-business and Accounting Student at the University of Notre Dame - Glynn Family Honors Scholar | Greater Chicago Area, United States |
View
|
| Alex Moeller | Neuroscience Student at the University of Notre Dame | Ada, Michigan, United States |
View
|
| Seth Flatt, Ms, Mba | Life Science Venture Builder - Oberlin College & University of Notre Dame Alum | South Bend, Indiana, United States |
Email
|
Employees by Management Level
Individual contributor
3 profiles
Compare Similar Companies to Abbio XR, Inc.
Student International Business Council (SIBC)
Higher Education
Putnam
Business Consulting And Services
Nucleate
Biotechnology Research
DressyClub
Retail Apparel And Fashion
Nephrogen
Biotechnology Research
SyzOnc
Biotechnology Research
Cloverleaf Bio
Biotechnology Research
Runwayz
Education
SereNeuro Therapeutics
Biotechnology Research
Vectorgram Health
Software Development